The life-support system called ECMO can rescue COVID-19 patients from the brink of death, but not at the rates seen early in the pandemic, a new international study finds.

Sending more ECMO circuits – the pumps, tubes and controllers used in the treatment – to these hospitals is not sufficient; specially trained teams, adequate blood supply and other factors are ...

Endothelial colony-forming cells (ECFCs), a subtype of EPCs, were isolated from blood collected from 12 neonatal extracorporeal membrane oxygenation (ECMO) circuits. ECFCs were isolated in all ...

However, IV infusion of MSCs in ECMO patients poses significant challenges, including the risk for circuit obstruction due to cell size and aggregation, which could compromise ECMO function and ...

An ECMO (extracorporeal membrane oxygenation) circuit in use to support a patient in an intensive care unit at Michigan Medicine, the University of Michigan's academic medical center.

Lifesaving device in short supply Hospitals across our state don't have enough ECMO devices to meet the high demand. As the country experiences this fourth surge of the COVID-19 pandemic, Anna ...

The method-named CIBA, for Consecutive Intrabronchial Administration -enables the delivery of stem-cell-based treatments directly into the alveoli of critically ill patients who cannot receive ...

"If this week continues, we're going to run out of ECMO circuits in the next two weeks. If the slope - if the rate of which we're putting people on ECMO right now continues to go up, we're going ...

The life-support system called ECMO can rescue COVID-19 patients from the brink of death, but not at the rates seen early in the pandemic, a new international study finds.

Until now, cell therapies were nearly impossible to administer to ECMO patients, as intravenous infusion risked clogging the system's gas-exchange membranes. The CIBA method solves this technical ...